Cannabis and Orthostatic Hypotension
THC acutely lowers standing blood pressure; cannabis is not a treatment for orthostatic hypotension.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
THC reliably drops your blood pressure when you stand — that's the opposite of helpful if you already struggle with dizziness or fainting on standing. There is zero evidence cannabis treats orthostatic hypotension. The marketing idea that 'cannabis is heart-healthy because it lowers BP' ignores that orthostatic drops, rapid heartbeat, and the risk of fainting are real harms, especially in older adults or people already on blood-pressure meds.
Not Medical Advice
This article is not medical advice. It summarizes published evidence about cannabis and orthostatic hypotension (OH). If you experience dizziness on standing, fainting, or have a diagnosis of POTS, autonomic neuropathy, or cardiovascular disease, talk to a clinician before using cannabis or changing any medication. Stopping antihypertensives or starting cannabis on the assumption it will 'balance' your blood pressure can cause serious harm.
Plain-Language Summary
Orthostatic hypotension is a drop in blood pressure when you stand up — typically defined as a fall of ≥20 mmHg systolic or ≥10 mmHg diastolic within 3 minutes of standing [1]. Symptoms include lightheadedness, blurred vision, and fainting.
THC, the main intoxicating cannabinoid in cannabis, acutely lowers standing blood pressure and increases heart rate. In controlled human studies, smoked or oral THC produces measurable orthostatic drops, sometimes with frank syncope, particularly in cannabis-naive subjects and older adults [2][3] Strong evidence. Some tolerance to these cardiovascular effects develops with repeated use [4] Weak / limited.
There is no good evidence that cannabis, THC, or CBD treats orthostatic hypotension. The pharmacology points the other direction. Cannabis is not recommended in any major clinical guideline for OH.
What Probably Works (for Orthostatic Hypotension — Not Cannabis)
Standard, evidence-based treatments for orthostatic hypotension include:
- Non-pharmacologic measures: increased fluid and salt intake, compression stockings, slow positional changes, physical counter-maneuvers (leg crossing, squatting) [1][5] Strong evidence.
- Midodrine: an α1-agonist that raises standing BP, FDA-approved for symptomatic OH [5] Strong evidence.
- Fludrocortisone: a mineralocorticoid that expands plasma volume [5] Strong evidence.
- Droxidopa: approved for neurogenic orthostatic hypotension [5] Strong evidence.
These are the evidence-based options. Cannabis does not appear in this category and is not in any major guideline for OH because it worsens, rather than improves, the core problem.
What Might Work — Or Is At Least Being Studied
CBD and blood pressure: There is a narrow theoretical distinction between CBD and THC. Acute CBD has been reported to modestly lower resting blood pressure in healthy volunteers without consistently producing orthostatic symptoms [6] Weak / limited. This is not a therapeutic effect for OH — if anything, lowering resting BP further would worsen orthostatic stress.
Symptom relief in autonomic dysfunction: Some patients with POTS or autonomic neuropathy report symptomatic relief from cannabis, primarily for associated nausea, pain, or sleep problems rather than the orthostatic component itself Anecdote. No controlled trials in POTS populations exist.
Endocannabinoid system and cardiovascular control: The endocannabinoid system is involved in cardiovascular autonomic regulation, and CB1 receptors are present on vascular smooth muscle and in brainstem cardiovascular centers [7] Strong evidence. Whether this pathway can be exploited therapeutically to raise standing BP or improve baroreflex function is unknown.
What Doesn't Work / Weak or No Evidence
- Cannabis as a treatment for orthostatic hypotension: no controlled trials, no mechanistic plausibility for raising standing BP, acute effects documented to worsen OH No data.
- 'Indica strains stabilize blood pressure': This is marketing folklore. Strain name and cannabinoid content are not reliable predictors of cardiovascular effects No data.
- 'Microdosing THC trains your autonomic system': No supporting evidence No data.
- CBD as a pressor agent: Implausible based on current data; reported acute effects are BP-lowering, not raising [6] Weak / limited.
- Cannabis for 'balancing' blood pressure: The popular claim that cannabis is cardiovascular-protective ignores that orthostatic drops, reflex tachycardia, and increased myocardial oxygen demand are not benign — particularly in older users [3][8] Strong evidence.
What We Don't Know
- Whether chronic, low-dose cannabis produces sustained changes in orthostatic tolerance after tolerance to acute cardiovascular effects develops.
- Whether specific cannabinoid ratios (e.g. high-CBD, low-THC) reduce orthostatic risk while preserving other therapeutic effects for comorbid conditions.
- Whether patients with POTS, neurogenic OH, or other dysautonomias respond differently from healthy cannabis users.
- Long-term effects on baroreflex sensitivity and cardiovascular autonomic function. Animal work suggests CB1 activation blunts baroreflex responses [7] Weak / limited, but human chronic-use data are sparse.
- Pharmacokinetic and pharmacodynamic interactions with midodrine, fludrocortisone, β-blockers, SNRIs, and other medications commonly used in dysautonomia.
Comparison With Standard Treatments
| Intervention | Direction of effect on standing BP | Evidence level |
|---|---|---|
| Midodrine | Raises | Strong [5] |
| Fludrocortisone | Raises (via plasma volume expansion) | Strong [5] |
| Droxidopa | Raises | Strong [5] |
| Non-pharmacologic (compression, hydration, counter-maneuvers) | Stabilizes or raises | Strong [1][5] |
| Acute THC | Lowers standing BP; raises heart rate | Strong [2][3] |
| Acute CBD | Slightly lowers resting BP | Weak [6] |
Cannabis sits on the wrong side of this table for OH treatment. For a patient with symptomatic orthostatic hypotension, adding cannabis is more likely to provoke syncope than relieve it.
Risks and Harms
- Syncope and falls: Acute THC increases the risk of fainting, especially in older adults, cannabis-naive users, and after rapid position changes. Emergency department reports describe cannabis-associated syncope in this context [3][8] Strong evidence.
- Reflex tachycardia: THC increases heart rate by 20–50% acutely, compounding orthostatic symptoms and increasing myocardial oxygen demand in patients with coronary disease [2] Strong evidence.
- Drug interactions: Additive hypotension with antihypertensives, nitrates, phosphodiesterase-5 inhibitors, and alcohol Weak / limited.
- Edibles and delayed onset: Edibles produce delayed and prolonged effects, making orthostatic symptoms harder to predict and avoid. Many emergency department visits for cannabis-related cardiovascular symptoms involve edibles [8] Weak / limited.
- Worsening in POTS: Some patients with POTS report worsening tachycardia and palpitations with THC, though controlled data are lacking Anecdote.
- Drug interactions with dysautonomia treatment: See Cannabis and Polypharmacy Risks for a detailed overview of interactions with cardiovascular and autonomic medications.
The Bottom Line
If you use cannabis and notice lightheadedness on standing, the practical answer is straightforward: lower the dose, stand slowly, hydrate well, avoid combining with alcohol or other BP-lowering drugs, and talk to a clinician — especially if you take blood pressure medication or have been diagnosed with autonomic dysfunction. There is no evidence that cannabis will help orthostatic hypotension, and substantial evidence that it will make it worse.
Sources
- Peer-reviewed Freeman R, Wieling W, Axelrod FB, et al. (2011). Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clinical Autonomic Research, 21(2), 69–72.
- Peer-reviewed Sidney S. (2002). Cardiovascular consequences of marijuana use. Journal of Clinical Pharmacology, 42(S1), 64S–70S.
- Peer-reviewed Jones RT. (2002). Cardiovascular system effects of marijuana. Journal of Clinical Pharmacology, 42(S1), 58S–63S.
- Peer-reviewed Benowitz NL, Jones RT. (1975). Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clinical Pharmacology & Therapeutics, 18(3), 287–297.
- Peer-reviewed Gibbons CH, Schmidt P, Biaggioni I, et al. (2017). The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. Journal of Neurology, 264(8), 1567–1582.
- Peer-reviewed Jadoon KA, Tan GD, O'Sullivan SE. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI Insight, 2(12), e93760.
- Peer-reviewed Pacher P, Bátkai S, Kunos G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews, 58(3), 389–462.
- Peer-reviewed Monte AA, Shelton SK, Mills E, et al. (2019). Acute illness associated with cannabis use, by route of exposure: An observational study. Annals of Internal Medicine, 170(8), 531–537.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis Use Disorder — A clinical diagnosis defined by impaired control, withdrawal, and harm—treatable with beha...